435 related articles for article (PubMed ID: 27733667)
1. Association Between Proton Pump Inhibitors and Microscopic Colitis.
Law EH; Badowski M; Hung YT; Weems K; Sanchez A; Lee TA
Ann Pharmacother; 2017 Mar; 51(3):253-263. PubMed ID: 27733667
[TBL] [Abstract][Full Text] [Related]
2. Comparative risk of ischemic stroke among users of clopidogrel together with individual proton pump inhibitors.
Leonard CE; Bilker WB; Brensinger CM; Flockhart DA; Freeman CP; Kasner SE; Kimmel SE; Hennessy S
Stroke; 2015 Mar; 46(3):722-31. PubMed ID: 25657176
[TBL] [Abstract][Full Text] [Related]
3. Myopathy including polymyositis: a likely class adverse effect of proton pump inhibitors?
Clark DW; Strandell J
Eur J Clin Pharmacol; 2006 Jun; 62(6):473-9. PubMed ID: 16758264
[TBL] [Abstract][Full Text] [Related]
4. The association between the use of proton pump inhibitors and the risk of hypomagnesemia: a systematic review and meta-analysis.
Park CH; Kim EH; Roh YH; Kim HY; Lee SK
PLoS One; 2014; 9(11):e112558. PubMed ID: 25394217
[TBL] [Abstract][Full Text] [Related]
5. Comparative effectiveness and acceptability of the FDA-licensed proton pump inhibitors for erosive esophagitis: A PRISMA-compliant network meta-analysis.
Li MJ; Li Q; Sun M; Liu LQ
Medicine (Baltimore); 2017 Sep; 96(39):e8120. PubMed ID: 28953640
[TBL] [Abstract][Full Text] [Related]
6. Microscopic colitis associated with omeprazole and esomeprazole exposure.
Wilcox GM; Mattia AR
J Clin Gastroenterol; 2009 Jul; 43(6):551-3. PubMed ID: 19142168
[TBL] [Abstract][Full Text] [Related]
7. Empirical treatment of outpatients with gastroesophageal reflux disease with proton pump inhibitors: A survey of Chinese patients (the ENLIGHT Study).
Lu B; Zhang L; Wang J; Wang B; Zou X; Fei G; Chen D; Wang X; Wu B; Zou D
J Gastroenterol Hepatol; 2018 Oct; 33(10):1722-1727. PubMed ID: 29575167
[TBL] [Abstract][Full Text] [Related]
8. Changes in CYP2C19 enzyme activity evaluated by the [(13)C]-pantoprazole breath test after co-administration of clopidogrel and proton pump inhibitors following percutaneous coronary intervention and correlation to platelet reactivity.
Harvey A; Modak A; Déry U; Roy M; Rinfret S; Bertrand OF; Larose É; Rodés-Cabau J; Barbeau G; Gleeton O; Nguyen CM; Proulx G; Noël B; Roy L; Paradis JM; De Larochellière R; Déry JP
J Breath Res; 2016 Jan; 10(1):017104. PubMed ID: 26815196
[TBL] [Abstract][Full Text] [Related]
9. Systematic review: proton pump inhibitors (PPIs) for the healing of reflux oesophagitis - a comparison of esomeprazole with other PPIs.
Edwards SJ; Lind T; Lundell L
Aliment Pharmacol Ther; 2006 Sep; 24(5):743-50. PubMed ID: 16918878
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of six proton pump inhibitors as inhibitors of various human cytochromes P450: focus on cytochrome P450 2C19.
Zvyaga T; Chang SY; Chen C; Yang Z; Vuppugalla R; Hurley J; Thorndike D; Wagner A; Chimalakonda A; Rodrigues AD
Drug Metab Dispos; 2012 Sep; 40(9):1698-711. PubMed ID: 22648560
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis: esomeprazole or rabeprazole vs. first-generation pump inhibitors in the treatment of Helicobacter pylori infection.
McNicholl AG; Linares PM; Nyssen OP; Calvet X; Gisbert JP
Aliment Pharmacol Ther; 2012 Sep; 36(5):414-25. PubMed ID: 22803691
[TBL] [Abstract][Full Text] [Related]
12. Associations of proton pump inhibitors and hospitalization due to hyponatremia: A population-based case-control study.
Falhammar H; Lindh JD; Calissendorff J; Skov J; Nathanson D; Mannheimer B
Eur J Intern Med; 2019 Jan; 59():65-69. PubMed ID: 30154038
[TBL] [Abstract][Full Text] [Related]
13. A randomized, 2-period, crossover design study to assess the effects of dexlansoprazole, lansoprazole, esomeprazole, and omeprazole on the steady-state pharmacokinetics and pharmacodynamics of clopidogrel in healthy volunteers.
Frelinger AL; Lee RD; Mulford DJ; Wu J; Nudurupati S; Nigam A; Brooks JK; Bhatt DL; Michelson AD
J Am Coll Cardiol; 2012 Apr; 59(14):1304-11. PubMed ID: 22464259
[TBL] [Abstract][Full Text] [Related]
14. Microscopic colitis associated with lansoprazole: report of two cases and a review of the literature.
Chande N; Driman DK
Scand J Gastroenterol; 2007 Apr; 42(4):530-3. PubMed ID: 17454866
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous reactions to proton pump inhibitors: a case-control study.
Chularojanamontri L; Jiamton S; Manapajon A; Suvanasuthi S; Kulthanan K; Dhana N; Jongjarearnprasert K
J Drugs Dermatol; 2012 Oct; 11(10):e43-7. PubMed ID: 23134998
[TBL] [Abstract][Full Text] [Related]
16. Systematic review: standard- and double-dose proton pump inhibitors for the healing of severe erosive oesophagitis -- a mixed treatment comparison of randomized controlled trials.
Edwards SJ; Lind T; Lundell L; DAS R
Aliment Pharmacol Ther; 2009 Sep; 30(6):547-56. PubMed ID: 19558609
[TBL] [Abstract][Full Text] [Related]
17. Use of proton pump inhibitors in the management of gastroesophageal varices: a systematic review.
Lo EA; Wilby KJ; Ensom MH
Ann Pharmacother; 2015 Feb; 49(2):207-19. PubMed ID: 25583938
[TBL] [Abstract][Full Text] [Related]
18. Possible drug-drug interaction between high-dose esomeprazole and phenprocoumon.
Becker ML; Franken WP; Karapinar F; Verzijl-Zeegers R; Schalekamp T; van der Hoeven RT
Eur J Clin Pharmacol; 2015 Dec; 71(12):1461-5. PubMed ID: 26400679
[TBL] [Abstract][Full Text] [Related]
19. Proton Pump Inhibitors Increase Risk for Hepatic Encephalopathy in Patients With Cirrhosis in A Population Study.
Tsai CF; Chen MH; Wang YP; Chu CJ; Huang YH; Lin HC; Hou MC; Lee FY; Su TP; Lu CL
Gastroenterology; 2017 Jan; 152(1):134-141. PubMed ID: 27639806
[TBL] [Abstract][Full Text] [Related]
20. Significant association between the use of different proton pump inhibitors and microscopic colitis: a nationwide Danish case-control study.
Bonderup OK; Nielsen GL; Dall M; Pottegård A; Hallas J
Aliment Pharmacol Ther; 2018 Sep; 48(6):618-625. PubMed ID: 30039564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
